Canadian Association for Population Therapeutics (CAPT) 2025
September 22-23, 2025 | Toronto, ON, Canada
The material below is to support scientific exchange. Any content about investigational therapeutics or investigational uses of FDA-approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of FDA approval.
Alnylam does not recommend or suggest use of its products in any manner inconsistent with the approved Prescribing Information.
Real-world experience with therapeutics for ATTR in the Canadian population
